title: ADAMTS4 (aggrecanase-1) cleaves human brain versican V2 at Glu405-Gln406 to generate glial hyaluronate binding protein.
abstract: Human brain tissue from cerebellum and hippocampus was obtained between 2 h and 24 h post mortem and, after extraction in the presence of proteinase inhibitors, proteoglycans were purified by anion-exchange chromatography. The versican component was characterized by Western analysis with antibodies to the N-terminal peptide (LF99), the N-terminal globular domain (12C5) and the two GAG (glycosaminoglycan) attachment regions (anti-GAG-alpha and anti-GAG-beta). The results indicated that versican V2 is the major variant in all brain samples, and that it exists as the full-length form and also as at least six C-terminally truncated forms. The major immunoreactive species present is a 64 kDa product, which we identified by biochemical and immunological analysis as the brain protein previously termed GHAP (glial hyaluronate binding protein) [Perides, Lane, Andrews, Dahl and Bignami (1989) J. Biol. Chem. 264, 5981-5987]. Immunological analysis of purified human GHAP using a new anti-neoepitope antiserum (JSCNIV) showed that its C-terminal sequence is NIVSFE(405), and digestion of human cerebellum proteoglycans with ADAMTS4 (aggrecanase-1, where ADAMTS, a disintegrin and metalloproteinase with thrombospondin-1-like motifs) indicated that GHAP is a product of cleavage of versican V0 or V2 at the Glu(405)-Gln(406) bond. Since human cerebellum extracts contained multiple forms of ADAMTS4 protein on Western analysis, these data suggest that one or more members of the 'aggrecanase' group of the ADAMTS family (ADAMTS 1, 4, 5 and 9) are responsible for turnover of versican V2 in the adult human brain.
authors.affiliation: Center for Research in Paediatric Orthopaedics, Shriners Hospital, Tampa, FL 33612, U.S.A.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Westling
authors.forename: Paul E
authors.initials: PE
authors.lastname: Gottschall
authors.forename: Vivian P
authors.initials: VP
authors.lastname: Thompson
authors.forename: Amber
authors.initials: A
authors.lastname: Cockburn
authors.forename: George
authors.initials: G
authors.lastname: Perides
authors.forename: Dieter R
authors.initials: DR
authors.lastname: Zimmermann
authors.forename: John D
authors.initials: JD
authors.lastname: Sandy
mesh_terms: D051722:ADAM Proteins; D000071121:ADAMTS4 Protein; D000595:Amino Acid Sequence; D000596:Amino Acids / Q000737:chemistry / Q000502:physiology; D001921:Brain / Q000201:enzymology*; D001923:Brain Chemistry; D002352:Carrier Proteins / Q000737:chemistry / Q000378:metabolism*; D011508:Chondroitin Sulfate Proteoglycans / Q000737:chemistry / Q000276:immunology / Q000378:metabolism*; D004220:Disulfides / Q000737:chemistry; D018698:Glutamic Acid / Q000378:metabolism*; D005973:Glutamine / Q000378:metabolism*; D006031:Glycosylation; D006801:Humans; D037181:Lectins, C-Type; D008666:Metalloendopeptidases / Q000378:metabolism*; D008969:Molecular Sequence Data; D008970:Molecular Weight; D009419:Nerve Tissue Proteins / Q000737:chemistry / Q000378:metabolism*; D010446:Peptide Fragments / Q000737:chemistry / Q000276:immunology; D010455:Peptides / Q000502:physiology; D017354:Point Mutation / Q000502:physiology; D011180:Postmortem Changes; D011237:Predictive Value of Tests; D011348:Procollagen N-Endopeptidase; D017434:Protein Structure, Tertiary; D013997:Time Factors; D014020:Tissue Extracts / Q000737:chemistry; D053675:Versicans
chemical_list: D000596:Amino Acids; D002352:Carrier Proteins; D011508:Chondroitin Sulfate Proteoglycans; D004220:Disulfides; D037181:Lectins, C-Type; D009419:Nerve Tissue Proteins; D010446:Peptide Fragments; D010455:Peptides; D014020:Tissue Extracts; C508322:VCAN protein, human; D005973:Glutamine; D053675:Versicans; D018698:Glutamic Acid; D051722:ADAM Proteins; D008666:Metalloendopeptidases; D011348:Procollagen N-Endopeptidase; D000071121:ADAMTS4 Protein; C000603918:ADAMTS4 protein, human